TGFB1 and cancer: TGFβ receptors and Smad4, a key TF in canonical TGFβ signaling, are frequently inactivated to boost experimental metastasis in animal models [18, 20–24], and it was proposed that TGFβ signaling acts on nonneoplastic stromal rather than cancer cells to promote metastases formation [25, 26].